Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Adicet Bio (ACET) said it has completed the last patient visit for the planned analysis of its prula-cel (formerly ADI-001) study in systemic lupus erythematosus with or without lupus nephritis, and provided a corporate update.
Adicet Bio says last patient visit is complete for planned analysis of prula-cel in systemic lupus erythematosus, with or without lupus nephritis, and provides a corporate update.